P-463 Preliminary results of a multicenter randomized phase II trial oftwo different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)
Bernardini, I., Rinaldi, M., Crinò, L., Nardi, M., De Marinis, F., Tonato, M., Sguotti, C., Vallauri, L., Scagliotti, G., Novello, S.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80956-0
Date:
July, 2005
File:
PDF, 130 KB
english, 2005